Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€1.14
20.12.23
-
20.12.24
8.80%
23.12.23

buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€1.33
20.12.23
-
20.12.24
-7.27%
23.12.23

buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€2.00
20.12.23
-
20.12.24
-38.15%
23.12.23

buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€2.14
19.12.23
-
19.12.24
-42.20%
23.12.23

buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€2.78
10.12.23
-
10.12.24
-55.50%
26.12.23

Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€2.78
09.12.23
€1.00
09.12.24
-55.50%
23.12.23

buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€4.00
02.12.23
€5.00
31.10.25
-30.50%
10.12.23

Could be very worthwhile Investment >20% year
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€19.62
30.11.23
-
30.11.24
12.62%
08.12.23

Could be very worthwhile Investment >20% year
buy
Blueprint Medicines Corp

Start price
Target price
Perf. (%)
€64.00
30.11.23
-
30.11.24
10.94%
31.01.24

buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€51.82
25.11.23
-
25.11.24
1.27%
09.12.23

buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€52.24
22.11.23
-
22.11.24
0.50%
12.12.23

Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€2.59
28.10.23
€1.00
28.10.24
8.65%
11.11.23

PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.20
28.10.23
€8.00
28.10.24
-4.07%
11.11.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
negative Cash Flow expected
buy
Insulet Corp.

Start price
Target price
Perf. (%)
€137.80
27.10.23
-
27.11.23
24.60%
28.11.23

buy
Davita Inc.

Start price
Target price
Perf. (%)
€72.54
11.10.23
-
11.10.24
-3.61%
14.10.23

buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€59.10
05.10.23
-
05.10.24
-8.93%
15.10.23

Could be worthwhile Investment >10% per year
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€19.60
30.09.23
€9.00
30.09.24
11.22%
14.10.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€24.00
16.09.23
€12.00
16.09.24
-13.33%
30.09.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
negative Cash Flow expected
buy
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€25.20
15.09.23
-
15.09.24
-4.76%
16.09.23

Could be very worthwhile Investment >20% year
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.90
11.08.23
-
11.08.24
-9.05%
19.08.23

buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.23
09.08.23
-
09.08.24
-5.69%
19.08.23

Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€15.10
07.08.23
-
07.08.24
21.19%
18.08.23

Capable Management
Risky Investment
No uniques
buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€0.95
07.08.23
-
07.08.24
-29.26%
19.08.23

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.70
07.08.23
-
07.08.24
8.38%
19.08.23

buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€30.60
31.07.23
-
31.07.24
-43.79%
05.08.23